Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myelomaFrédéric Pène, Didier Bouscary, Yann-Érick Claessens et al.|Oncogene|2002Cited by 298
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Françoise Picard, F Viguié et al.|Blood|2009Cited by 270
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AMLSophie Park, Didier Bouscary, Nicolas Chapuis et al.|Leukemia|2008Cited by 193